Romania

Terapia SA

An EMIS Company Report EMIS is a Euromoney Institutional Investor plc company USD 29.95 Industry: Pharmaceutical and Medicine Manufacturing Available in: English & Romanian Format: PDF Download Most recent financial data: 2016 Buy full report

What’s included?

This report extracts all available information about Terapia SA from EMIS' database of company information. The Table of Contents on the right indicates the categories of information that will be included in your report upon purchase.

Download a sample report

Company Tear Sheet (locked content will be provided in the purchased report)

Contact Information

Headquarters
Strada Fabricii, Nr. 124
CLUJ-NAPOCA; Cluj; Map
Postal Code: 003400

Tel: +40 264 501 ; +40 264 501 ; +40 264 501 ; +40 264 501
Fax: +40 264 415 ; +40 721 215

Email:
@terapia.ro; financiar@ranbaxy.com; romania.office@sunfarma.com;

Website:
http://www.sunpharma.com

Company Description
Established in 1921, Terapia is the largest generic pharmaceutical company in Romania with strong brands and a consistent track record of growth. Terapia SA has a large product portfolio and a robust distribution network, including the largest generic sales force in the country. On 8 June 2006, Ranbaxy Laboratories Ltd. announced the completion of acquisition by Ranbaxy Netherlands BV of 96.7% of Terapia SA. After this acquisition, the company was liquidated, saw the establishment of a new company with the trade name of Terapia Ranbaxy, keeping legal name of Terapia SA. Today company become a subsidiary of Sun Pharmaceutical Industries Ltd.
NAICS Industry Classification
Main Activities: Pharmaceutical and Medicine Manufacturing
Basic Information
Total Employees:
852 (2016)
Registered Capital:
()
Financial Auditors:
()
Incorporation Date:
January 01, 2004
Profile Updated:
November 16, 2017
Key Executives
General Manager
Administrator
Administrator
Administrator
Administrator
More
Ownership Details
Ranbaxy (Netherlands) B.V.Olanda (Netherlands)
96.7%
Key Financial Highlights
2016 Y
Net sales revenue
Total operating revenue
Operating profit (EBIT)
EBITDA
Net Profit (Loss) for the Period
Total assets 865,159
Total equity
Operating Profit (EBIT) Margin
Return on Sales (ROS)
Return on Equity (ROE)
Debt to Equity
Quick Ratio
Cash Ratio
Note: units in Thousands. Statement: Non-Audited, Individual
Source: Creditinfo Romania, EMIS Company Database.
Financial Performance Charts
Top Competitors

Financial Statements

Annual Statements

EMIS Credit Analytics

EMIS Benchmark Score
Enterprise ACCESS

If you need regular and ongoing access to company information, you should consider a subscription to the full EMIS service.

EMIS company profiles are part of a larger information service where that combines company, industry and country data and analysis for over 125 emerging markets on a unique information platform.

REQUEST A DEMO

To view more information, REQUEST A DEMO